Pre-clinical results published in the Journal of Neuro-Interventional Surgery. Technology presented at the World Live Neurovascular Conference. Technology selected as a top 3 finalist for Innovator of the Year by the Congress of Neurological Surgeons. Raised a Series A to fund commercialization (FDA Clearance, Health Canada, ISO 13485, First-in-man and early revenue).
Trade on Vena Medical
Vena Medical shares
No active listings yet.
Be the first to post →